Lumos Pharma Inc Forecast, price target & analysts
Lumos Pharma Inc Target price 2024 - Analyst rating & recommendation
Lumos Pharma Inc Classifications & Recommendation:
Lumos Pharma Inc Target price
| Target price | $18.00 |
| Course | $2.32 |
| Price potential |
675.86%
register free of charge
|
| Number of estimates | 2 |
|
2 Analysts have issued a price target Lumos Pharma Inc 2025 .
The average Lumos Pharma Inc target price is $18.00.
This is
675.86%
register free of charge
$20.00
762.07%
register free of charge
$16.00
589.66%
register free of charge
|
|
| A rating was issued by 3 analysts: 3 Analysts recommend Lumos Pharma Inc to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst estimates: Analysts believe that the Lumos Pharma Inc share has an average upside potential 2025 of
675.86%
register free of charge
|
Sales and margin forecast 2024, 2025 to 2028
| Dec '23 |
2024 Forecast |
|
|---|---|---|
| Turnover Million $ | 2.05 | 13.97 |
| 34.87% | 581.22% | |
| Net margin | -1,653.65% | -165.51% |
| 16.46% | 89.99% |
3 Analysts have issued a sales forecast Lumos Pharma Inc 2024 . The average Lumos Pharma Inc sales estimate is
This results in the following potential growth figures:
3 Lumos Pharma Inc Analysts have issued a net profit forecast 2024. The average Lumos Pharma Inc net profit estimate is
This results in the following potential growth figures and future net margins:
Earnings per share, P/E ratio and EV/sales forecast 2024, 2025 to 2028
| Dec '23 |
2024 Forecast |
|
|---|---|---|
| Earnings per share $ | -4.18 | -2.85 |
| 12.67% | 31.82% | |
| P/E ratio | negative | |
| EV/Sales | 0.16 |
3 Analysts have issued a Lumos Pharma Inc forecast for earnings per share. The average Lumos Pharma Inc <a href=/blog/eps>EPS is
This results in the following potential growth figures and future valuations:
Based on analysts' sales estimates for 2024, the Lumos Pharma Inc share is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of
This results in the following potential growth figures and future valuations:
Lumos Pharma Inc...
Discover more stocks with a high price target
Register for free
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.
